Mupirocin resistance in nasal carriage ofStaphylococcus aureusamong healthcare workers of a tertiary care rural hospital
Authors:
Open Access
- 1 November 2014
- journal article
- Published by Jaypee Brothers Medical Publishing in Indian Journal of Critical Care Medicine
- Vol. 18 (11) , 716-721
Abstract
Mupirocin (pseudomonic acid A) is a topical antimicrobial agent with excellent antistaphylococcal and antistreptococcal activity. A nasal formulation is approved by the United States Food and Drug Administration for eradicating nasal carriage in adult patients as well as in health care personnel. Resistance to mupirocin has already been reported worldwide. The increasing prevalence of mupirocin resistance among Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) species could be an important threat to the future use of mupirocin against methicillin-resistant S. aureus (MRSA). Thus, this study was carried out to find the prevalence of mupirocin resistance in S. aureus and CoNS by disc diffusion and to determine the rates of high-level and low-level mupirocin resistance in S. aureus and CoNS by disc diffusion. A total of 140 healthcare workers (HCWs) (doctor, nursing staff, housekeeping staff) were randomly selected. S. aureus and CoNS isolates were tested for mupirocin resistance by the disk diffusion method using 5 μg and 200 μg mupirocin discs. MRSA isolates were tested for antibiotics by Kirby-Bauer disc-diffusion method as per Clinical and Laboratory Standards Institute guidelines. Out of 140 nasal swabs collected from HCWs, S. aureus was isolated in 38 (27.14%), and CoNS was isolated in 73 (52.14%). MRSA was isolated in 20 (14.28%) and methicillin-resistant coagulase-negative Staphylococci (MRCoNS) in 34 (24.29%. Methicillin-sensitive S. aureus (MSSA) and MSCoNS isolates were 100% sensitive to mupirocin, but two isolates from MRSA (1.43%) and five from MRCoNS (3.57%) were mupirocin resistant. The presence of mupirocin resistance in MRSA and MRCoNS is a cause for concern. It could be limited by regular surveillance and effective infection control initiatives so to inform health care facilities to guide therapeutic and prophylactic use of mupirocin.Keywords
This publication has 29 references indexed in Scilit:
- The Prevalence of Nasal Carriage of Staphylococcus Aureus Among Healthcare Workers at a Tertiary Care Hospital in Assam with Special Reference to MRSAJournal of Clinical and Diagnostic Research, 2013
- MupB, a New High-Level Mupirocin Resistance Mechanism in Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2012
- Mupirocin resistance in clinical isolates of staphylococci in a tertiary care centre in south IndiaIndian Journal of Medical Microbiology, 2010
- Staphylococcus aureus nasal carriage rate and associated risk factors in individuals in the communityEpidemiology and Infection, 2009
- PREVALENCE OF NASAL COLONIZATION WITH METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) IN CHILDREN A MULTICENTER CROSS-SECTIONAL STUDYThe Pediatric Infectious Disease Journal, 2007
- Genetic Basis of Resistance to Fusidic Acid in StaphylococciAntimicrobial Agents and Chemotherapy, 2007
- In vivo transfer of high-level mupirocin resistance from Staphylococcus epidermidis to methicillin-resistant Staphylococcus aureus associated with failure of mupirocin prophylaxisJournal of Antimicrobial Chemotherapy, 2005
- Treatment of Staphylococcus aureus Colonization and Prophylaxis for Infection with Topical Intranasal Mupirocin: An Evidence-Based ReviewClinical Infectious Diseases, 2003
- The Epidemiology of Mupirocin Resistance Among Methicillin-ResistantStaphylococcus aureusat a Veterans' Affairs HospitalInfection Control & Hospital Epidemiology, 2000
- Antibiotics for treatment of infections caused by MRSA and elimination of MRSA carriage. What are the choices?International Journal of Antimicrobial Agents, 1997